Prudential Financial Inc (PRU) Stock Price Today
Key Stats
- $42.71BMarket Cap
- -Volume
- FinancialsSector
- $123.9352W High
- $92.0052W Low
- -Typical Hold Time
- $69.77BEnterprise Value
- 4.55%Div Yield
- -Trading Activity
Track Prudential Financial Inc (PRU) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Prudential Financial Inc has traded between a low of $92 and a high of $123.93, highlighting its annual price range. Buy and sell Prudential Financial Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Most Recent News
Bunge Global SA gains insider buy and analyst boost, with price target up 28%
Bunge Global SA saw a director purchase 1,500 shares at $107.60, signaling insider confidence. Analysts have set a mean price target of $138.30, implying a 28.3% upside, driven by strong Q2 performance in soybeans and softseeds that raised earnings o...
Stocks plunge amid inverse ETF drops, legal probes, and earnings worries.
Stocks fell sharply due to various factors including a 58.71% drop in the Defiance Daily Target 2x Short PLTR ETF, driven by strong gains in Palantir Technologies, which the ETF inversely tracks. AdaptHealth shares dropped 38.09% amid a legal investi...
Law firm probes Karyopharm over executive retention bonuses amid stock price drop
Pomerantz LLP is investigating Karyopharm Therapeutics for potential securities fraud related to a retention program granting top executives lump sum cash bonuses between $625,000 and $1,725,000. The announcement led to a 21.45% drop in Karyopharm's ...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.